BH3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PTC Therapeutics Inc

Watchlist Manager

Watchlist

Price: 62.62 EUR 3.44% Market Closed

Market Cap: €4.8B

	PTC Therapeutics Inc F:BH3	US
A	Aperam SA SWB:7AA	LU
D	Diageo PLC BMV:DEON	UK
	Best Buy Co Inc NYSE:BBY	US
	Aperam SA F:7AA	LU
	Marubeni Corp F:MAR0	JP
W	Wharf Holdings Ltd OTC:WARFF	HK
	Republic Bancorp Inc NASDAQ:RBCAA	US

Profitability Summary

PTC Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

82%

Declining Gross Margin

94% > 93%

Healthy Operating Margin

12%

Low 3Y Average Operating Margin

Operating Margin is Increasing

-42% > 12%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-13%

Net Margin is Increasing

-75% > -4%

Negative Free Cash Flow Margin

-4%

Strong 3Y Average Free Cash Flow Margin

29%

Free Cash Flow Margin is Increasing

-39% > -4%

Positive ROE

21%

Positive 3Y Average ROE

Positive 3Y Average ROIC

24%

ROIC is Increasing

-30% > 9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.